Why Mission Produce (AVO) Shares Are Plunging Today

Mission Produce (AVO) shares fell 11.3% after setting 5-year targets: mid-single-digit sales growth, 300 bps margin expansion, and 2035 goals to double sales and triple EBITDA. The company raised Calavo synergy targets to over $30M. Q3 revenue was $450M, up 25.8% YoY, beating estimates. Adjusted EPS was $0.18, a 56.5% beat. Stock is down 4.1% YTD, 27.6% off 52-week high.

Original reporting
Published Oct 8, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 5:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Mission Produce (AVO) Shares Are Plunging Today — source image
Decision brief

The 30-second read

$AVOBearishMed
01

Why it matters

The stock’s sharp intraday decline suggests the market either viewed the multi-year targets as insufficient, too execution-dependent, or not aligned with prior expectations for growth and free-cash-flow conversion.

02

Market read

Traders can reassess AVO’s valuation and risk premium based on the new five-year targets and the market’s immediate negative reaction.

03

What to watch

The margin goal depends on mix and asset utilization plus synergy timing; traders may be discounting execution risk or integration costs, but the article also notes synergy contribution starting in Q4 and accelerating through fiscal 2027.

Relevance 7/10Novelty 6/10Timing: same-day afternoon selloff after the 2026 Investor Day targets

Background

Mission Produce held a 2026 Investor Day and disclosed a five-year financial framework, including organic growth, margin expansion, synergy updates from the Calavo Growers deal, and a deleveraging target.

Company-level read

Ticker impact

$AVOBearishMedium confidence
Context

Mission Produce shares fell 11.3% after its 2026 Investor Day unveiled five-year targets, including mid-single-digit organic growth and 300 bps margin expansion.

Expected impact

Likely further downside pressure as traders reassess the credibility and timing of margin expansion, synergy realization, and deleveraging path.

Evidence & confidence

The article ties the afternoon 11.3% drop directly to the Investor Day targets and highlights specific drivers (Calavo synergies, mix, overhead reduction, asset utilization) that may be viewed as execution-dependent.

Market effects

Could modestly affect sentiment toward packaged produce and avocado supply-chain equities by reinforcing how investors price synergy and margin-expansion plans.

Limited, as the catalyst is company-specific and tied to a US-listed issuer’s Investor Day.

Low, since the disclosed targets and Calavo synergy update are not a broad global macro driver.

Counterpoint

The targets include raised Calavo synergy to more than $30M and a leverage reduction plan, which could be interpreted as improving fundamentals despite the initial selloff.

Key entities

  • Mission Produce

    AVO, avocado company that disclosed five-year targets and updated Calavo synergy expectations at its 2026 Investor Day.

  • Calavo Growers

    Acquired entity whose synergies Mission Produce is using as a key driver for margin expansion and cash flow.

Related articles

$AVOMed

Mission Produce Unveils Five-Year Financial Targets and Strategies at 2026 Investor Day

Mission Produce (AVO) hosted its 2026 Investor Day, outlining five-year targets: mid-single-digit organic sales growth, 300 basis points of margin expansion, and 90% cash conversion. The company aims to double sales and triple Adjusted EBITDA by 2035, supported by Calavo integration, Prepared Foods expansion, and asset utilization. Management expects high-single-digit to double-digit annual shareholder returns.

$AVOMed

Mission Produce unveils five-year targets, $100M buyback, aims to double sales and triple EBITDA by 2035

Mission Produce announced a five-year plan with mid-single-digit organic sales growth, 300bps margin expansion, and 2035 targets to double sales to $4B and triple Adjusted EBITDA to $450M. The company reaffirmed fiscal 2H26 Adjusted EBITDA outlook of $84–88M and Q426 Adjusted EBITDA of $52–55M. It also launched a $100M share repurchase program, with 290,994 shares repurchased at an average price of $12.94.

$AVOMedAI 8/10

Acquisition Momentum Offset by Profitability Headwinds for Mission Produce (AVO)

Mission Produce (AVO) reported Q3 FY26 adjusted EBITDA of $32.4M, beating expectations. Revenue rose 26% YoY to $450M, driven by avocado supply growth and the Calavo acquisition. However, profitability declined, with adjusted net income down YoY. Q4 adjusted EBITDA is projected at $52M-$55M, incorporating Calavo benefits. Institutional investment remained steady, with 20 hedge funds holding shares.

$CALMMed

Maine (NASDAQ:CALM) Vs The Rest Of The Perishable Food Stocks

Cal-Maine Foods (CALM) reported Q2 revenue of $552.6M, down 49.9% YoY, missing estimates by 2%. Mission Produce (AVO) reported $450M revenue, up 25.8% YoY, beating estimates. Flowers Foods (FLO) and Tyson Foods (TSN) missed estimates. Freshpet (FRPT) reported $305.6M revenue, up 15.5% YoY, beating estimates. Perishable food stocks are down 8.8% on average since earnings.